Concepedia

Anna-Lisa Lanz

AL

Statistics

Publications

8

Citations

392

H-Index

8

Active since

2008

Affiliations

Ludwig-Maximilians-Universität München(Current)

Inserm

Rockefeller University

Aix-Marseille Université

University Hospital Bonn

Anna-Lisa Lanz is an author at Ludwig-Maximilians-Universität München specializing in immunology, life sciences, and innate immunity.

ORCID

Publications per year

2008–2024

8

Publications

8

Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity

Carole Bourquin, David Anz, Klaus Zwiorek et al. · The Journal of Immunology · 2008 · 151 citations · Full text

, , +17

Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia

Ana García‐García, Rebeca Pérez de Diego, Carlos Flores et al. · The Journal of Experimental Medicine · 2023 · 56 citations · Full text

, , +15

Allosteric activation of T cell antigen receptor signaling by quaternary structure relaxation

Anna-Lisa Lanz, Giulia Masi, Nicla Porciello et al. · Cell Reports · 2021 · 47 citations · Full text

, , +17

Immunostimulatory RNA Oligonucleotides Induce an Effective Antitumoral NK Cell Response through the TLR7

Carole Bourquin, Laura S. Schmidt, Anna-Lisa Lanz et al. · The Journal of Immunology · 2009 · 42 citations · Full text

, , +17

Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency

Romain Lévy, Florian Gothe, Mana Momenilandi et al. · The Journal of Experimental Medicine · 2022 · 39 citations · Full text

, , +17

1–5 of 8